Intended for healthcare professionals

Primary Care

Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study)

BMJ 2004; doi: (Published 11 February 2004) Cite this as: BMJ 2004;:bmj;bmj.37970.629537.0Dv1

This article has a correction. Please see:

PDF extract preview

This is a PDF-only article. The first page of the PDF of this article appears above.